australia takes gsk novartis to court
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice
Emiratesvoice, emirates voice
Last Updated : GMT 05:17:37
Emiratesvoice, emirates voice

Over 'Misleading' Claims

Australia takes GSK, Novartis to court

Emiratesvoice, emirates voice

Emiratesvoice, emirates voice Australia takes GSK, Novartis to court

GSK acquired Novartis' portfolio of Voltaren
Sydney - Emirates Voice

Drug giants GlaxoSmithKline and Novartis are being taken to court by Australia's consumer watchdog over "false or misleading" claims in the marketing of pain relief products, it was announced Wednesday.

The case by the Australian Competition and Consumer Commission centres around their Voltaren Osteo Gel and Voltaren Emulgel lines.

It claims they represented Osteo Gel on its packaging and online as specifically formulated for treating osteoarthritis and was more effective than Emulgel, when they had identical formulas.

Both products contain the same active ingredient, diclofenac diethylammonium gel 11.6mg/g, which acts in a non-specific manner to reduce local pain and inflammation wherever it is applied.

"We allege that consumers are likely to have been misled into purchasing Osteo Gel thinking that it is different to Emulgel and more effective for treating osteoarthritis conditions, when this is not the case," ACCC chairman Rod Sims said.

"In fact, the product has an identical formulation to Emulgel, and both products are equally effective in treating not only osteoarthritis, but also a range of other pain conditions."

Price sampling conducted by the ACCC at supermarkets and pharmacies found that Osteo Gel was often sold at a significant premium to Emulgel.

"We allege GSK and Novartis engaged in a deliberate commercial strategy to differentiate the products in a way that was likely to mislead consumers," added Sims, with the case headed for the Federal Court.

"The alleged conduct is particularly concerning, given the significant penalties handed down by the court against the makers of Nurofen for what we consider to be similar conduct."

A year ago, Reckitt Benckiser was slapped with a Aus$6 million (US$4.4 million) fine for making misleading claims about its popular Nurofen Specific Pain brand in Australia.

The ACCC disputed Nurofen packaging claims that products in the range were formulated to treat different types of pain, when the active ingredient was the same.

GSK said it was disappointed proceedings had commenced.

"We have been cooperating with them (ACCC) and proactively trying to understand their concerns related to our products, however to date they have not provided clarity about the basis for their concern," it said in a statement.

The British pharmaceuticals giant acquired Novartis' portfolio of Voltaren products in 2016 and has been responsible for marketing and selling them since then.

Source: AFP

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

australia takes gsk novartis to court australia takes gsk novartis to court

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

australia takes gsk novartis to court australia takes gsk novartis to court

 



GMT 05:06 2024 Tuesday ,06 February

New hunt for flight MH370 gets under way

GMT 05:17 2024 Wednesday ,07 February

Amazon to open first cashierless shop

GMT 16:17 2018 Thursday ,30 August

Five Saudi women pilots granted GACA licences

GMT 05:14 2024 Wednesday ,07 February

Sophisticated Classic Dining Room Design Ideas

GMT 15:28 2017 Friday ,06 January

Girl’s ears cut off for resisting rape

GMT 12:17 2017 Sunday ,04 June

UN imposes targeted sanctions on North Korea

GMT 22:14 2011 Sunday ,18 September

Nepal holds first international literary festival

GMT 00:36 2016 Tuesday ,27 December

Abbas condoles with Putin over plane crash victims

GMT 07:33 2017 Thursday ,25 May

Riad Quaider said opulation format in Tunisia

GMT 20:33 2011 Tuesday ,13 September

Algerian director among Tangier film festival jury

GMT 08:07 2017 Tuesday ,07 March

Peru president targeted in Odebrecht bribery probe

GMT 11:48 2013 Wednesday ,08 May

AMU must resolve Western Sahara conflict

GMT 00:47 2017 Monday ,27 February

17.4 million tourists visit UAE in 2016

GMT 15:17 2017 Tuesday ,15 August

Emaar Properties records 22 percent growth

GMT 05:08 2017 Sunday ,15 January

Johnny Depp, Amber Heard finalize divorce

GMT 18:25 2015 Saturday ,14 November

Prince halts Europe tickets over inflated resale

GMT 21:45 2017 Thursday ,21 September

Healthcare not just about medicines, hears summit

GMT 13:54 2016 Monday ,05 September

At 82, Jane Goodall embraces modern technology

GMT 20:33 2017 Monday ,06 March

Pakistan to reopen border for stranded Afghans
Emiratesvoice, emirates voice
 
 Emirates Voice Facebook,emirates voice facebook  Emirates Voice Twitter,emirates voice twitter Emirates Voice Rss,emirates voice rss  Emirates Voice Youtube,emirates voice youtube  Emirates Voice Youtube,emirates voice youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©

emiratesvoieen emiratesvoiceen emiratesvoiceen emiratesvoiceen
emiratesvoice emiratesvoice emiratesvoice
emiratesvoice
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
emiratesvoice, Emiratesvoice, Emiratesvoice